Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 7, 1999, Pages 1556-1559

  Mazzei, Teresita ^a   Surrenti, Calogero ^a   Novelli, Andrea ^a   Biagini, Maria Rosa ^a   Fallani, Stefania ^a   Cassetta, Maria Iris ^a   Conti, Silvia ^a   Surrenti, Elisabetta ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DIRITHROMYCIN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; AREA UNDER THE CURVE; ARTICLE; BILIARY CIRRHOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG URINE LEVEL; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY CLEARANCE; LIVER CIRRHOSIS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032810992     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.7.1556     Document Type: Article

References (14)

1. Brogden, R. N., and D. H. Peters. 1994. Dirithromycin: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 48:599-616.
2. Chu, S. Y., G. R. Granneman, P. J. Pichotta, J. P. Decourt, J. Girault, and J. B. Fourtillan. 1993. Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics. J. Clin. Pharmacol. 33:480-485.
3. Counter, F. T., P. W. Ensminger, D. A. Preston, C.-Y. E. Wu, J. M. Greene, A. M. Felty-Duckworth, J. W. Paschal, and H. A. Kirst. 1991. Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin. Antimicrob. Agents Chemother. 35:1116-1126.
4. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
5. Kucers, A., and N. Bennett. 1987. Erythromycin, p. 851-882. In The use of antibiotics. A comprehensive review with clinical emphasis. 4th ed. William Heinemann, London, United Kingdom.
6. Labrecque, D. R., F. Johlin, R. Janda, T. Shreves, D. Geraets, K. DeSante, B. Cerimele, T. Lanier, and G. Sides. 1993. Pharmacokinetics of dirithromycin in patients with impaired hepatic function. J. Antimicrob. Chemother. 32:741-750.
7. Le Couteur, D. G., and A. J. McLean. 1998. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin. Pharmacokinet. 34:359-373.
8. Mazzel, T., C. Surrenti, A. Novelli, A. Crispo, S. Fallani, V. Carlà, E. Surrenti, and P. Periti. 1993. Pharmacokinetics of azithromycin in patients with impaired hepatic function. J. Antimicrob. Chemother. 31(Suppl. E):57-63.
9. Miglioli, P. A., P. Pivetta, R. Orlando, P. Palatini, A. Varotto, and L. Okolicsanyi. 1989. Pharmacokinetics of miocamycin in patients with liver cirrhosis. Chemotherapy (Base 1) 35:330-332.
10. Periti, P., T. Mazzei, E. Mini, and A. Novelli. 1989. Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (parts I-II). Clin. Pharmacokinet. 16:193-214, 261-282.
11. Pugh, R. N. H., I. M. Murray-Lyon, J. L. Dawson, M. C. Pietroni, and R. Williams. 1973. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60:646-649.
12. Schmucker, D. L. 1998. Aging and the liver: an update. J. Gerontol. A Biol. Sci. Med. Sci. 53:B315-B320.
13. Sides, G. D., B. J. Cerimele, H. R. Black, U. Busch, and K. A. DeSante. 1993. Pharmacokinetics of dirithromycin. J. Antimicrob. Chemother. 31(Suppl. C): 65-75.
14. Woodhouse, K., and H. A. Wynne. 1992. Age-related changes in hepatic function. Implications for drug therapy. Drugs Aging 2:243-255.